<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34209673</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle><i>C9orf72</i> Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6991</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22136991</ELocationID><Abstract><AbstractText>A cytokine storm, autoimmune features and dysfunctions of myeloid cells significantly contribute to severe coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Genetic background of the host seems to be partly responsible for severe phenotype and genes related to innate immune response seem critical host determinants. The <i>C9orf72</i> gene has a role in vesicular trafficking, autophagy regulation and lysosome functions, is highly expressed in myeloid cells and is involved in immune functions, regulating the lysosomal degradation of mediators of innate immunity. A large non-coding hexanucleotide repeat expansion (HRE) in this gene is the main genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), both characterized by neuroinflammation and high systemic levels of proinflammatory cytokines, while HREs of intermediate length, although rare, are more frequent in autoimmune disorders. <i>C9orf72</i> full mutation results in haploinsufficiency and intermediate HREs seem to modulate gene expression as well and impair autophagy. Herein, we sought to explore whether intermediate HREs in <i>C9orf72</i> may be a risk factor for severe COVID-19. Although we found intermediate HREs in only a small portion of 240 patients with severe COVID-19 pneumonia, the magnitude of risk for requiring non-invasive or mechanical ventilation conferred by harboring intermediate repeats &gt;10 units in at least one <i>C9orf72</i> allele was more than twice respect to having shorter expansions, when adjusted for age (odds ratio (OR) 2.36; 95% confidence interval (CI) 1.04-5.37, <i>p</i> = 0.040). The association between intermediate repeats &gt;10 units and more severe clinical outcome (<i>p</i> = 0.025) was also validated in an independent cohort of 201 SARS-CoV-2 infected patients. These data suggest that <i>C9orf72</i> HREs &gt;10 units may influence the pathogenic process driving more severe COVID-19 phenotypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zanella</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3902-3376</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacchi</LastName><ForeName>Eliana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious and Tropical Diseases, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piva</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Division of Anesthesiology and Critical Care Medicine, ASST Spedali Civili, 25123 Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filosto</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2852-7512</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeMo-Brescia Clinical Center for Neuromuscular Diseases, 25064 Gussago, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beligni</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alaverdian</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Genetica Medica, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fava</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4363-2353</Identifier><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetica Medica, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldassarri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0391-1980</Identifier><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frullanti</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meloni</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renieri</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0846-9220</Identifier><AffiliationInfo><Affiliation>Medical Genetics, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetica Medica, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>GEN-COVID Multicenter Study</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>GEVACOBA Study Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Castelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9161-7804</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious and Tropical Diseases, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiros-Roldan</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1452-9100</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious and Tropical Diseases, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>unconditional grant (E.Q-R)</GrantID><Agency>ViiV Healthcare</Agency><Country/></Grant><Grant><GrantID>ex 60% (I.Z.)</GrantID><Agency>Universit&#xe0; degli Studi di Brescia</Agency><Country/></Grant><Grant><GrantID>project "Dipartimenti di Eccellenza 2018-2020" to the Department of Medical Biotechnologies University of Siena, Italy (Italian D.L. n.18 March 17, 2020)</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant><Grant><GrantID>for COVID-19 research</GrantID><Agency>private donors</Agency><Country/></Grant><Grant><GrantID>"Bando Ricerca COVID-19 Toscana"</GrantID><Agency>Azienda Ospedaliero-Universitaria Senese</Agency><Country/></Grant><Grant><GrantID>N. B/2020/0119 "Identificazione delle basi genetiche determinanti la variabilit&#xe0; clinica della risposta a COVID-19 nella popolazione italiana</GrantID><Agency>charity fund 2020 from Intesa San Paolo</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018895" MajorTopicYN="Y">Microsatellite Repeats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">genetic risk</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">intermediate alleles</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Mari</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daga</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benetti</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furini</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valentino</LastName><ForeName>Floriana</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doddato</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giliberti</LastName><ForeName>Annarita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tita</LastName><ForeName>Rossella</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruttini</LastName><ForeName>Mirella</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croci</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mencarelli</LastName><ForeName>Maria Antonietta</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lo Rizzo</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montagnani</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Sarno</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palmieri</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carriero</LastName><ForeName>Miriam Lucia</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabbiani</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rancan</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossetti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bargagli</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergantini</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Alessandro</LastName><ForeName>Miriana</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cameli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennet</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anedda</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scolletta</LastName><ForeName>Sabino</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franchi</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzei</LastName><ForeName>Maria Antonietta</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerrini</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conticini</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cantarini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frediani</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tacconi</LastName><ForeName>Danilo</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spertilli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feri</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donati</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scala</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guidelli</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spargi</LastName><ForeName>Genni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corridi</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nenicioni</LastName><ForeName>Cesira</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croci</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caldarelli</LastName><ForeName>Gian Piero</ForeName><Initials>GP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spagnesi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romani</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piacentini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bandini</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desanctis</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cappelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canaccini</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verzuri</LastName><ForeName>Agnese</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anemoli</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ognibene</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pancrazi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lorubbio</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaghu</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Arminio Monforte</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miraglia</LastName><ForeName>Federica Gaia</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monedlli</LastName><ForeName>Mario U</ForeName><Initials>MU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruno</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vecchia</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ludovisi</LastName><ForeName>Serena</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venturelli</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Busani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cossarizza</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antinori</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vergori</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Emiliozzi</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rusconi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siano</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabrieli</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riva</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francisci</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiaroli</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paciosi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tommasi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scotton</LastName><ForeName>Pier Giorgio</ForeName><Initials>PG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andretta</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panese</LastName><ForeName>Sandro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scaggiante</LastName><ForeName>Renzo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gatti</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parisi</LastName><ForeName>Saverio Giuseppe</ForeName><Initials>SG</Initials></Investigator><Investigator ValidYN="Y"><LastName>degli Antoni</LastName><ForeName>Melania</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Della Monica</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piscopo</LastName><ForeName>Carmelo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capasso</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russo</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andolfo</LastName><ForeName>Immacolata</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iolascon</LastName><ForeName>Achille</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorentino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carella</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castori</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merla</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Squeo</LastName><ForeName>Gabriella Maria</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aucella</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raggi</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marciano</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perna</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bassetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Biagio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanguinetti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masucci</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valente</LastName><ForeName>Serafina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mandal&#xe0;</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giorli</LastName><ForeName>Alessia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salerni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zucchi</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parravicini</LastName><ForeName>Pierpaolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menatti</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baratti</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trotta</LastName><ForeName>Tullio</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giannattasio</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coiro</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lena</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coviello</LastName><ForeName>Domenico A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mussini</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bosio</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mancarella</LastName><ForeName>Sandro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tavecchia</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belli</LastName><ForeName>Mary Ann</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crotti</LastName><ForeName>Lia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parati</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Picchiotti</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gori</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabbi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanarico</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ceri</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinoli</LastName><ForeName>Pietro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raimondi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biscarini</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stella</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maggiolo</LastName><ForeName>Franco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ripamonti</LastName><ForeName>Diego</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suardi</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bachetti</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>La Rovere</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sarzi-Braga</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bussotti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capitani</LastName><ForeName>Katia</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zguro</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dei</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravaglia</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artuso</LastName><ForeName>Rosangela</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrella</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergomi</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Catena</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perticaroli</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gennarelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magri</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basiotto</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zizioli</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giliani</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monti</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foc&#xe0;</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carriero</LastName><ForeName>Cannio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Latronico</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padovani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brugnoni</LastName><ForeName>Duilio</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34209673</ArticleId><ArticleId IdType="pmc">PMC8268051</ArticleId><ArticleId IdType="doi">10.3390/ijms22136991</ArticleId><ArticleId IdType="pii">ijms22136991</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Cao C., Qin X.-Y., Yu Y., Yuan J., Zhao Y., Cheng Y. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: A meta-analysis study. Sci. Rep. 2017;7:1&#x2013;9. doi: 10.1038/s41598-017-09097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09097-1</ArticleId><ArticleId IdType="pmc">PMC5567306</ArticleId><ArticleId IdType="pubmed">28831083</ArticleId></ArticleIdList></Reference><Reference><Citation>Theuns J., Verstraeten A., Sleegers K., Wauters E., Gijselinck I., Smolders S., Crosiers D., Corsmit E., Elinck E., Sharma M., et al. Global investigation and meta-analysis of the C9orf72 (G4C2) n repeat in Parkinson disease. Neurology. 2014;83:1906&#x2013;1913. doi: 10.1212/WNL.0000000000001012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001012</ArticleId><ArticleId IdType="pmc">PMC4248456</ArticleId><ArticleId IdType="pubmed">25326098</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannas A., Solla P., Borghero G., Floris G.L., Chi&#xf2; A., Mascia M.M., Modugno N., Muroni A., Orofino G., Di Stefano F., et al. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson&#x2019;s disease complicated by psychosis or dementia in a Sardinian population. J. Neurol. 2015;262:2498&#x2013;2503. doi: 10.1007/s00415-015-7873-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7873-6</ArticleId><ArticleId IdType="pubmed">26275564</ArticleId></ArticleIdList></Reference><Reference><Citation>Solje E., Miettunen J., Marttila R., Helisalmi S., Laitinen M., Koivumaa-Honkanen H., Isohanni M., Hiltunen M., J&#xe4;&#xe4;skel&#xe4;inen E., Remes A.M. The C9ORF72 expansion sizes in patients with psychosis. Psychiatr. Genet. 2016;26:92&#x2013;94. doi: 10.1097/YPG.0000000000000118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YPG.0000000000000118</ArticleId><ArticleId IdType="pubmed">26862832</ArticleId></ArticleIdList></Reference><Reference><Citation>Meloni M., Farris R., Solla P., Mascia M.M., Marrosu F., Cannas A. C9ORF72 Intermediate Repeat Expansion in a Patient with Psychiatric Disorders and Progressive Cerebellar Ataxia. Neurology. 2017;22:245&#x2013;246. doi: 10.1097/NRL.0000000000000147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NRL.0000000000000147</ArticleId><ArticleId IdType="pubmed">29095328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng A.S.L., Tan E.-K. Intermediate C9orf72 alleles in neurological disorders: Does size really matter? J. Med. Genet. 2017;54:591&#x2013;597. doi: 10.1136/jmedgenet-2017-104752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2017-104752</ArticleId><ArticleId IdType="pmc">PMC5574395</ArticleId><ArticleId IdType="pubmed">28689190</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiloca C., Sorosina M., Esposito F., Peroni S., Colombrita C., Ticozzi N., Ratti A., Martinelli-Boneschi F., Silani V. No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis. Mult. Scler. Relat. Disord. 2018;25:192&#x2013;195. doi: 10.1016/j.msard.2018.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2018.07.047</ArticleId><ArticleId IdType="pubmed">30099204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali C.P., Patino M., Tai Y.K., Ho W.Y., McLean C.A., Morris C.M., Seeley W.W., Miller B.L., Gaig C., Vonsattel J.P.G., et al. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy. Acta Neuropathol. 2019;138:795&#x2013;811. doi: 10.1007/s00401-019-02045-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02045-5</ArticleId><ArticleId IdType="pmc">PMC6802287</ArticleId><ArticleId IdType="pubmed">31327044</ArticleId></ArticleIdList></Reference><Reference><Citation>Biasiotto G., Zanella I. The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases. Mult. Scler. Relat. Disord. 2019;27:42&#x2013;43. doi: 10.1016/j.msard.2018.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2018.10.004</ArticleId><ArticleId IdType="pubmed">30312838</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredi M., Cavazzana I., Biasiotto G., Filosto M., Padovani A., Monti E., Tincani A., Franceschini F., Zanella I. C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis. Neuromolecular Med. 2019;21:150&#x2013;159. doi: 10.1007/s12017-019-08528-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-019-08528-8</ArticleId><ArticleId IdType="pubmed">30859373</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W., Hu F. Cellular and physiological functions of C9ORF72 and implications for ALS/FTD. J. Neurochem. 2021;157:334&#x2013;350. doi: 10.1111/jnc.15255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15255</ArticleId><ArticleId IdType="pubmed">33259633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan P.M., Zhou X., Robins A.M., Paushter D.H., Kim D., Smolka M.B., Hu F. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol. Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R.A., Levina V., Halloran M.A., Gleeson P., Blair I., Soo K.Y., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Bauer C.S., Moller A., Hautbergue G.M., Ferraiuolo L., Myszczynska M., Higginbottom A., Walsh M.J., Whitworth A.J., et al. The C9orf72 protein interacts with Rab1a and the ULK 1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbier C., Sellier C. C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy. Small GTPases. 2017;8:181&#x2013;186. doi: 10.1080/21541248.2016.1212688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1212688</ArticleId><ArticleId IdType="pmc">PMC5584738</ArticleId><ArticleId IdType="pubmed">27494456</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y., Manzano R., Lee Y., Dafinca R., Aoki M., Douglas A.G.L., Varela M.A., Sathyaprakash C., Scaber J., Barbagallo P., et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897. doi: 10.1093/brain/awx024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx024</ArticleId><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D., Sheng J., Xu L., Yan C., Qi S. The C9orf72-SMCR8-WDR41 complex is a GAP for small GTPases. Autophagy. 2020;16:1542&#x2013;1543. doi: 10.1080/15548627.2020.1779473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1779473</ArticleId><ArticleId IdType="pmc">PMC7469575</ArticleId><ArticleId IdType="pubmed">32521185</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Burberry A., Wang J.-Y., Sandoe J., Ghosh S., Udeshi N.D., Svinkina T., Mordes D.A., Mok J., Charlton M., et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 2018;32:929&#x2013;943. doi: 10.1101/gad.313932.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.313932.118</ArticleId><ArticleId IdType="pmc">PMC6075033</ArticleId><ArticleId IdType="pubmed">29950492</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Wang J. C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism. Autophagy. 2019;15:913&#x2013;914. doi: 10.1080/15548627.2019.1580106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1580106</ArticleId><ArticleId IdType="pmc">PMC6526819</ArticleId><ArticleId IdType="pubmed">30767689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan Y., Sullivan P.M., Hu F. SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis. Autophagy. 2019;15:871&#x2013;885. doi: 10.1080/15548627.2019.1569914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569914</ArticleId><ArticleId IdType="pmc">PMC6526807</ArticleId><ArticleId IdType="pubmed">30696333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Wang H., Tao Z., Xia Q., Hao Z., Prehn J.H.M., Zhen X., Wang G., Ying Z. C9orf72 associates with inactive Rag GTPases and regulates mTORC1-mediated autophagosomal and lysosomal biogenesis. Aging Cell. 2020;19:e13126. doi: 10.1111/acel.13126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13126</ArticleId><ArticleId IdType="pmc">PMC7189992</ArticleId><ArticleId IdType="pubmed">32100453</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q., Yang M., Liang C., Ma L., Zhang W., Jiang Z., Luo J., Lee J.-K., Liang C., Chen J.-F. C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy. 2020;16:1635&#x2013;1650. doi: 10.1080/15548627.2019.1703353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1703353</ArticleId><ArticleId IdType="pubmed">31847700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzu P., Blauwendraat C., Heetveld S., Lynes E.M., Castillo-Lizardo M., Dhingra A., Pyz E., Hobert M., Synofzik M., Sim&#xf3;n-S&#xe1;nchez J., et al. C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathol. Commun. 2016;4:37. doi: 10.1186/s40478-016-0306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0306-7</ArticleId><ArticleId IdType="pmc">PMC4832459</ArticleId><ArticleId IdType="pubmed">27079381</ArticleId></ArticleIdList></Reference><Reference><Citation>Deretic V., Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018;14:243&#x2013;251. doi: 10.1080/15548627.2017.1402992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1402992</ArticleId><ArticleId IdType="pmc">PMC5902214</ArticleId><ArticleId IdType="pubmed">29165043</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A., Decman V., White D., Ramos M., Ikiz B., Lee H.-C., Siao C.-J., Brydges S., LaRosa E., Bai Y., et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K.M.G., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Suzuki N., Wang J.-Y., Moccia R., Mordes D.A., Stewart M.H., Suzuki-Uematsu S., Ghosh S., Singh A., Merkle F.T., et al. Loss-of-function mutations in theC9ORF72mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 2016;8:347ra93. doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine W., Sun L., Wang K.-W., Liu A., Jain R., Miguel M.S., Wang J., Zhang Z., Hayse B., McAlpine S.G., et al. Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function. Proc. Natl. Acad. Sci. USA. 2018;115:E11523&#x2013;E11531. doi: 10.1073/pnas.1814753115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814753115</ArticleId><ArticleId IdType="pmc">PMC6298088</ArticleId><ArticleId IdType="pubmed">30442666</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., O&#x2019;Rourke J.G., Y&#xe1;&#xf1;ez A., Markman J.L., Ho R., Wang X., Chen S., Lall D., Jin M., Muhammad A.K.M.G., et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nat. Cell Biol. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Zee J., Gijselinck I., Dillen L., Van Langenhove T., Theuns J., Engelborghs S., Philtjens S., Vandenbulcke M., Sleegers K., Sieben A., et al. A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate. Repeats. Hum. Mutat. 2012;34:363&#x2013;373. doi: 10.1002/humu.22244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22244</ArticleId><ArticleId IdType="pmc">PMC3638346</ArticleId><ArticleId IdType="pubmed">23111906</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B., Newhouse S., Shatunov A., Vance C., Topp S., Johnson L., Miller J.W., Lee Y., Troakes C., Scott K.M., et al. The C9ORF72 expansion mutation is a common cause of ALS+/&#x2212;FTD in Europe and has a single founder. Eur. J. Hum. Genet. 2012;21:102&#x2013;108. doi: 10.1038/ejhg.2012.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2012.98</ArticleId><ArticleId IdType="pmc">PMC3522204</ArticleId><ArticleId IdType="pubmed">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., On Behalf of the BELNEU Consortium. Van Mossevelde S., Van Der Zee J., Sieben A., Engelborghs S., De Bleecker J., Ivanoiu A., Deryck O., Edbauer D., et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol. Psychiatry. 2016;21:1112&#x2013;1124. doi: 10.1038/mp.2015.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.159</ArticleId><ArticleId IdType="pmc">PMC4960451</ArticleId><ArticleId IdType="pubmed">26481318</ArticleId></ArticleIdList></Reference><Reference><Citation>Leskel&#xe4; S., Huber N., Rostalski H., Natunen T., Remes A.M., Takalo M., Hiltunen M., Haapasalo A. C9orf72 Proteins Regulate Autophagy and Undergo Autophagosomal or Proteasomal Degradation in a Cell Type-Dependent Manner. Cells. 2019;8:1233. doi: 10.3390/cells8101233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101233</ArticleId><ArticleId IdType="pmc">PMC6829620</ArticleId><ArticleId IdType="pubmed">31658762</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M., Pfister V., Gaucherot A., Ruffenach F., Negroni L., Sellier C., Charlet-Berguerand N. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39:e100574. doi: 10.15252/embj.2018100574.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018100574</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M.F., Limone F., Couto A., Smith K.S., Keaney J., Gillet G., van Gastel N., Wang J.-Y., Pietilainen O., et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nat. Cell Biol. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera J.R., Rodr&#xed;guez-Izquierdo I., Jim&#xe9;nez J.L., Mu&#xf1;oz-Fern&#xe1;ndez M.&#xc1;. Analysis of ALS-related proteins during herpes simplex virus-2 latent infection. J. Neuroinflammation. 2020;17:371. doi: 10.1186/s12974-020-02044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02044-4</ArticleId><ArticleId IdType="pmc">PMC7722435</ArticleId><ArticleId IdType="pubmed">33287823</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., Sharif K., O&#x2019;Regan A., Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun. Rev. 2020;19:102537. doi: 10.1016/j.autrev.2020.102537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102537</ArticleId><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., Alijotas-Reig J., Zinserling V., Semenova N., Amital H., et al. Covid-19 and autoimmunity. Autoimmun. Rev. 2020;19:102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E., Clohisey S., Klaric L., Bretherick A.D., Rawlik K., Pasko D., Walker S., Parkinson N., Fourman M.H., Russell C.D., et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92&#x2013;98. doi: 10.1038/s41586-020-03065-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03065-y</ArticleId><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D.J., Adamopoulos I.E. Autophagy and autoimmunity. Clin. Immunol. 2017;176:55&#x2013;62. doi: 10.1016/j.clim.2017.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2017.01.007</ArticleId><ArticleId IdType="pmc">PMC5346336</ArticleId><ArticleId IdType="pubmed">28095319</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Maria E., Latini A., Borgiani P., Novelli G. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): Rapid systematic review and field synopsis. Hum. Genom. 2020;14:30. doi: 10.1186/s40246-020-00280-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-020-00280-6</ArticleId><ArticleId IdType="pmc">PMC7484929</ArticleId><ArticleId IdType="pubmed">32917282</ArticleId></ArticleIdList></Reference><Reference><Citation>Domdom M.-A., Brest P., Grosjean I., Rom&#xe9;o B., Landi M.T., Gal J., Klionsky D.J., Hofman P., Mograbi B. A multifactorial score including autophagy for prognosis and care of COVID-19 patients. Autophagy. 2020;16:2276&#x2013;2281. doi: 10.1080/15548627.2020.1844433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1844433</ArticleId><ArticleId IdType="pmc">PMC7751655</ArticleId><ArticleId IdType="pubmed">33249989</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Conforti F.L., Zollino M., Mora G., Monsurr&#xf2; M.R., Volanti P., Marinou K., Salvi F., Corbo M., Giannini F., et al. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol. Aging. 2012;33:1848.e15&#x2013;1848.e20. doi: 10.1016/j.neurobiolaging.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3372681</ArticleId><ArticleId IdType="pubmed">22418734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaivola K., Salmi S.J., Jansson L., Launes J., Hokkanen L., Niemi A.-K., Majamaa K., Lahti J., Eriksson J.G., Strandberg T., et al. Carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is a risk factor for ALS in the Finnish population. Acta Neuropathol. Commun. 2020;8:1&#x2013;9. doi: 10.1186/s40478-020-01059-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01059-5</ArticleId><ArticleId IdType="pmc">PMC7654028</ArticleId><ArticleId IdType="pubmed">33168078</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamim U., Ambawat S., Singh J., Thomas A., Pradeep-Chandra-Reddy C., Suroliya V., Uppilli B., Parveen S., Sharma P., Chanchal S., et al. C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: A common founder and its geographical predilection. Neurobiol. Aging. 2020;88:156.e1&#x2013;156.e9. doi: 10.1016/j.neurobiolaging.2019.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.12.024</ArticleId><ArticleId IdType="pubmed">32035847</ArticleId></ArticleIdList></Reference><Reference><Citation>Daga S., GEN-COVID Multicenter Study. Fallerini C., Baldassarri M., Fava F., Valentino F., Doddato G., Benetti E., Furini S., Giliberti A., et al. Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research. Eur. J. Hum. Genet. 2021;29:745&#x2013;759. doi: 10.1038/s41431-020-00793-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00793-7</ArticleId><ArticleId IdType="pmc">PMC7811682</ArticleId><ArticleId IdType="pubmed">33456056</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.-H., Hung S.-T., Hendricks E., Linares G.R., Wang Y., Son E.Y., et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson D.W., Baker M.C., Jackson J.L., DeJesus-Hernandez M., Finch N.A., Tian S., Heckman M.G., Pottier C., Gendron T.F., Murray M.E., et al. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol. Commun. 2019;7:1&#x2013;21. doi: 10.1186/s40478-019-0797-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0797-0</ArticleId><ArticleId IdType="pmc">PMC6781370</ArticleId><ArticleId IdType="pubmed">31594549</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y., Bowman J.W., Jung J.U. Autophagy during viral infection&#x2014;A double-edged sword. Nat. Rev. Microbiol. 2018;16:341&#x2013;354. doi: 10.1038/s41579-018-0003-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0003-6</ArticleId><ArticleId IdType="pmc">PMC6907743</ArticleId><ArticleId IdType="pubmed">29556036</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-P&#xe9;rez B.E., Gonz&#xe1;lez-Rojas J.A., Salazar M.I., Torres-Torres C., Castrej&#xf3;n-Jim&#xe9;nez N.S. Taming the Autophagy as a Strategy for Treating COVID-19. Cells. 2020;9:2679. doi: 10.3390/cells9122679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122679</ArticleId><ArticleId IdType="pmc">PMC7764362</ArticleId><ArticleId IdType="pubmed">33322168</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K., McGrath M.E., Hu Z., Ariannejad S., Weston S., Frieman M., Jackson W.T. Coronavirus interactions with the cellular autophagy machinery. Autophagy. 2020;16:2131&#x2013;2139. doi: 10.1080/15548627.2020.1817280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1817280</ArticleId><ArticleId IdType="pmc">PMC7755319</ArticleId><ArticleId IdType="pubmed">32964796</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaderi T., Bareke H., Kunter I., Seytanoglu A., Cagnan I., Balci D., Barin B., Hocaoglu M.B., Rahmioglu N., Asilmaz E., et al. Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity. Front. Immunol. 2020;11:586111. doi: 10.3389/fimmu.2020.586111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.586111</ArticleId><ArticleId IdType="pmc">PMC7783411</ArticleId><ArticleId IdType="pubmed">33414783</ArticleId></ArticleIdList></Reference><Reference><Citation>The Severe Covid-19 GWAS Group Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N. Engl. J. Med. 2020;383:1522&#x2013;1534. doi: 10.1056/NEJMoa2020283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Initiative A.D.N., Al Khleifat A., Jones A.R., Sproviero W., Shatunov A., Opie-Martin S., Morrison K.E., Shaw P., Shaw C.E., et al. C9orf72 intermediate expansions of 24&#x2013;30 repeats are associated with ALS. Acta Neuropathol. Commun. 2019;7:1&#x2013;7. doi: 10.1186/s40478-019-0724-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0724-4</ArticleId><ArticleId IdType="pmc">PMC6637621</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId></ArticleIdList></Reference><Reference><Citation>Beer A.M., Cooper-Knock J., Higginbottom A., Highley J.R., Wharton S.B., Ince P.G., Milano A., Jones A.A., Al-Chalabi A., Kirby J., et al. Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology. Amyotroph. Lateral Scler. Front. Degener. 2014;16:249&#x2013;251. doi: 10.3109/21678421.2014.977296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.977296</ArticleId><ArticleId IdType="pubmed">25436637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E., Shaw P.G., Kim M.-S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nat. Cell Biol. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R., Cabrera G.T., Andrade N.S., Gendron T.F., Brown R.H., Benatar M., Wahlestedt C., Mueller C., Zeier Z. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD. Mol. Neurodegener. 2017;12:46. doi: 10.1186/s13024-017-0185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0185-9</ArticleId><ArticleId IdType="pmc">PMC5468954</ArticleId><ArticleId IdType="pubmed">28606110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y., Xue Y.C., Liu H., Ng C.S., Bahreyni A., Jan E., Luo H. The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy. Biochem. Biophys. Res. Commun. 2021;540:75&#x2013;82. doi: 10.1016/j.bbrc.2020.12.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.12.091</ArticleId><ArticleId IdType="pmc">PMC7836930</ArticleId><ArticleId IdType="pubmed">33450483</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao G., Zhao H., Li Y., Ji M., Chen Y., Shi Y., Bi Y., Wang P., Zhang H. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev. Cell. 2021;56:427&#x2013;442.e5. doi: 10.1016/j.devcel.2020.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.12.010</ArticleId><ArticleId IdType="pmc">PMC7832235</ArticleId><ArticleId IdType="pubmed">33422265</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmakar D., Lahiri B., Ranjan P., Chatterjee J., Lahiri P., Sengupta S. Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity. Pathogens. 2020;10:5. doi: 10.3390/pathogens10010005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10010005</ArticleId><ArticleId IdType="pmc">PMC7823523</ArticleId><ArticleId IdType="pubmed">33374748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R., Wang N., Comish P.B., Tang D., Kang R. Inflammasome-Dependent Coagulation Activation in Sepsis. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.641750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.641750</ArticleId><ArticleId IdType="pmc">PMC8007875</ArticleId><ArticleId IdType="pubmed">33796108</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., O&#x2019;Donnell J.S., Sharif K., Emery P., Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437&#x2013;e445. doi: 10.1016/S2665-9913(20)30121-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30121-1</ArticleId><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhang R., He G. Hematological findings in coronavirus disease 2019: Indications of progression of disease. Ann. Hematol. 2020;99:1421&#x2013;1428. doi: 10.1007/s00277-020-04103-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04103-5</ArticleId><ArticleId IdType="pmc">PMC7266734</ArticleId><ArticleId IdType="pubmed">32495027</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowiec A., D&#x105;browski R., Kowalik I., Rusinowicz T., Hadzik-B&#x142;aszczyk M., Krupa R., &#x17b;yci&#x144;ska K. Elevated levels of d-dimer are associated with inflammation and disease activity rather than risk of venous thromboembolism in patients with granulomatosis with polyangiitis in long term observation. Adv. Med. Sci. 2020;65:97&#x2013;101. doi: 10.1016/j.advms.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2019.12.007</ArticleId><ArticleId IdType="pubmed">31923773</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyan H.M., Dogan S., Bal T., &#xc7;abalak M. Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19. Life Sci. 2021;278:119596. doi: 10.1016/j.lfs.2021.119596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119596</ArticleId><ArticleId IdType="pmc">PMC8107047</ArticleId><ArticleId IdType="pubmed">33984360</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy N.A., Arthur K.C., Tienari P.J., Houlden H., Chi&#xf2; A., Traynor B.J. Age-related penetrance of the C9orf72 repeat expansion. Sci. Rep. 2017;7:1&#x2013;7. doi: 10.1038/s41598-017-02364-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02364-1</ArticleId><ArticleId IdType="pmc">PMC5437033</ArticleId><ArticleId IdType="pubmed">28522837</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Batliwalla F., Li W., Lee A., Roubenoff R., Beckman E., Khalili H., Damle A., Kern M., Plenge R.M., et al. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in Rheumatoid Arthritis. Mol. Med. 2008;14:575&#x2013;581. doi: 10.2119/2008-00056.Liu.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2008-00056.Liu</ArticleId><ArticleId IdType="pmc">PMC2276142</ArticleId><ArticleId IdType="pubmed">18615156</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley I.T.W., Niewold T.B., Stormont R.M., Kaufman K.M., Glenn S.B., Franek B.S., Kelly J., Kilpatrick J.R., Hutchings D., Divers J., et al. The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus. J. Biomed. Biotechnol. 2010;2010:1&#x2013;11. doi: 10.1155/2010/706825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/706825</ArticleId><ArticleId IdType="pmc">PMC2914299</ArticleId><ArticleId IdType="pubmed">20706608</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.Y., Yang T.M., Ou R.W., Wei Q.Q., Shang H.F. Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases. BMC Med. 2021;19:1&#x2013;11. doi: 10.1186/s12916-021-01903-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01903-y</ArticleId><ArticleId IdType="pmc">PMC7863260</ArticleId><ArticleId IdType="pubmed">33541344</ArticleId></ArticleIdList></Reference><Reference><Citation>Brice D.C., Figgins E., Yu F., Diamond G. Type I interferon and interferon-stimulated gene expression in oral epithelial cells. Mol. Oral Microbiol. 2019;34:245&#x2013;253. doi: 10.1111/omi.12270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/omi.12270</ArticleId><ArticleId IdType="pmc">PMC7362904</ArticleId><ArticleId IdType="pubmed">31520463</ArticleId></ArticleIdList></Reference><Reference><Citation>Biasiotto G., Archetti S., Di Lorenzo D., Merola F., Paiardi G., Borroni B., Alberici A., Padovani A., Filosto M., Bonvicini C., et al. A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. Mol. Cell. Probes. 2017;32:60&#x2013;64. doi: 10.1016/j.mcp.2016.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcp.2016.10.008</ArticleId><ArticleId IdType="pubmed">27765650</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck J., Poulter M., Hensman D., Rohrer J.D., Mahoney C.J., Adamson G., Campbell T., Uphill J., Borg A., Fratta P., et al. Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population. Am. J. Hum. Genet. 2013;92:345&#x2013;353. doi: 10.1016/j.ajhg.2013.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.01.011</ArticleId><ArticleId IdType="pmc">PMC3591848</ArticleId><ArticleId IdType="pubmed">23434116</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S., van der Zee J., Cruts M., Van Broeckhoven C. Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 2017;44:117&#x2013;124. doi: 10.1016/j.gde.2017.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.02.008</ArticleId><ArticleId IdType="pubmed">28319737</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>